Immunovant Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2022 | -33.4% | -33.4% | -30.4% |
| FY2023 | -58.2% | -58.2% | -52.0% |
| FY2024 | -42.0% | -42.0% | -38.9% |
| FY2025 | -58.5% | -58.5% | -53.3% |
| FY2026 | -59.3% | -59.3% | -52.8% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2022 | -33.4% | -33.4% | -30.4% |
| FY2023 | -58.2% | -58.2% | -52.0% |
| FY2024 | -42.0% | -42.0% | -38.9% |
| FY2025 | -58.5% | -58.5% | -53.3% |
| FY2026 | -59.3% | -59.3% | -52.8% |